ducovest

XDJE:F:F-Xtrackers - Nikkei 225 UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 57.9

Change

+0.31 (+0.54)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Currency: EUR

Country : Germany

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

N/A

 USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

N/A

 USD 117.56B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

 USD 97.02B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

 USD 89.53B
EUNL:F iShares Core MSCI World UCITS ..

N/A

 USD 72.04B
FRCJ:F UBS MSCI Japan Socially Respon..

N/A

 USD 71.25B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

 USD 58.22B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

 USD 56.96B
VUAA:F Vanguard S&P 500 UCITS Acc

N/A

 USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

N/A

 USD 51.63B

ETFs Containing XDJE:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.31% 91% A- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.31% 89% A- 73% C
Trailing 12 Months  
Capital Gain 23.88% 80% B- 76% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.88% 78% C+ 68% D+
Trailing 5 Years  
Capital Gain 89.53% 91% A- 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 89.53% 91% A- 70% C-
Average Annual (5 Year Horizon)  
Capital Gain 14.46% 91% A- 80% B-
Dividend Return 14.46% 90% A- 74% C
Total Return N/A 99% N/A 100% F
Risk Return Profile  
Volatility (Standard Deviation) 18.33% 26% F 64% D
Risk Adjusted Return 78.92% 92% A 92% A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.